Aldehyde-Low Endothelial Progenitor Cells in Ischemic Wound Repair, Regulated by SDF1/CXCR4

Authors

  • Dias Rima Sutiono Indonesia International Institute for Life Sciences (i3L), Jakarta, Indonesia
  • Candra Louis Indonesia International Institute for Life Sciences (i3L), Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v45i12.689

Keywords:

Alde-low EPCs, CXCR4, HIF2α, SDF1

Abstract

The incidence rate of both ischemic heart disease and ischemic stroke over the past decade has become a concern in the respect of global mortality rate. Ischemia is a condition of oxygen deprivation in the specific tissue which leads to loss of organ function. Regenerative medicine by using the endothelial progenitor cells (EPCs) show a great potential, especially the Alde-Low EPCs. The Alde-Low EPCs are regulated mainly by the chemo-attractant proteins of SDF1/CXCR4 which responsible for the cell migration and is regulated by the HIF2α. Further investigation and research on the correlation of SDF1/CXCR4 and the Alde-Low EPCs are needed.

Peningkatan kejadian dan kematian akibat penyakit jantung iskemik dan stroke iskemik secara global pada beberapa dasawarsa telah menjadi perhatian. Upaya regenerasi menggunakan sel progenitor endothelial (EPCs) memperlihatkan potensi sangat tinggi, khususnya Alde-rendah EPCs. Alde-rendah EPCs diregulasi oleh protein kemoatraktan dari SDF1/CXCR4 yang bertanggung jawab untuk migrasi sel dan diregulasikan oleh HIF2α. Hubungan SDF1/CXCR4 dan Alde-rendah EPCs masih perlu diteliti lebih lanjut.

Downloads

Download data is not yet available.

References

Hong WX, Hu MS, Esquivel M, Liang GY, Rennert RC, McArdle A, et al. The role of hypoxia-inducible factor in wound healing. Adv. Wound Care 2014;3:390–9

Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24:288-93.

Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol. 2004;24:1442–7

Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004;35:233-45.

Vasiliou V, Pappa A, Estey T. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab Rev. 2004;36:279–99.

Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006;24:975– 85.

Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1:555–67

Ibrahim TR, Raouf SMA, Hegazy A. Immunohistochemical expression of aldehyde dehydrogenase-1 and hypoxia- inducible. IJAR. 2014;2(7): 822–30.

Kim RJ, Park JR, Roh KJ, Choi AR, Kim SR, Kim PH, et al. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxiainducible factor-2α. Cancer Lett. 2013;333(1):18- 31

Nagano M, Yamashita T, Hamada H, Ohneda K, Kimura K, Nakagawa T, et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 2006;110(1):151–61. doi:10.1182/blood-2006-10-047092.

Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001;414:550–4

Hoenig MR, Bianchi C, Rosenzweig A, Sellke FW. Decreased vascular repair and neovascularization with ageing: Mechanisms and clinical relevance with an emphasis on hypoxia-inducible factor-1. Curr Mol Med. 2008;8(8):754–67.

Tu TC, Nagano M, Yamashita T, Hamada H, Ohneda K, Kimura K, et al. A Chemokine receptor, CXCR4, which is regulated by hypoxia-inducible factor 2a, is crucial for functional endothelial progenitor cells migration to ischemic tissue and wound repair. Stem Cells Dev. 2016;25(3): 266–76. doi:10.1089/scd.2015.0290

Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-9.

Nakamura K, Tsurushima H, Marushima A, Nagano M, Yamashita T, Suzuki K, et al. A subpopulation of endothelial progenitor cells with low aldehyde dehydrogenase activity attenuates acute ischemic brain injury in rats. Biochem Biophys Res Comm. 2012;418(1):87–92. doi:10.1016/j.bbrc.2011.12.139

Debnath B, Xu S, Grande F, Garofalo A, Neamati N. Small molecule inhibitors of CXCR4. Theranostics 2013(1). doi:10.7150/thno.5376

Jones RJ, Barber JP, Vala MS, Collector MI, Kaufmann SH, Ludeman SM, et al. Assessment of aldehyde dehydrogenase in viable cells. Blood. 1995;85:2742-6.

Lopez-Holgado N, Alberca M, Sánchez-Guijo F, Villarón E, Almeida J, Martín A, et al. Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. Cytotherapy. 2007;9:14–22

Nagano M, Yamashita, Hamada H, Ohneda K, Kimura K, Nakagawa T, et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 2006;110(1):151–61. doi:10.1182/blood-2006-10-047092

Downloads

Published

03-12-2018

How to Cite

Sutiono, D. R., & Louis, C. (2018). Aldehyde-Low Endothelial Progenitor Cells in Ischemic Wound Repair, Regulated by SDF1/CXCR4. Cermin Dunia Kedokteran, 45(12), 935–937. https://doi.org/10.55175/cdk.v45i12.689

Issue

Section

Articles